ZIFIBANCIMIG
UNII 4UIR9KL62T

Substance Identification & Data

This profile provides standardized clinical and technical data for Zifibancimig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4UIR9KL62T.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2517939-46-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4UIR9KL62T

CAS Registry Number

2517939-46-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZIFIBANCIMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190348

National Cancer Institute reference terminology for clinical and research data.

INN ID

12086

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zifibancimig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZIFIBANCIMIG

Common Names & Synonyms

IMMUNOGLOBULIN FAB G1-KAPPA, ANTI-(HOMO SAPIENS ANGPT2 (ANGIOPOIETIN 2, ANG2)) AND ANTI-(HOMO SAPIENS VEGFA (VASCULAR ENDOTHELIAL GROWTH FACTOR A, VEGF-A, VEGF), MONOCLONAL ANTIBODY, BISPECIFIC, BIPARATOPE MONOVALENT

IMMUNOGLOBULIN G1 FAB FRAGMENT, BISPECIFIC, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A AND ANGIOPOIETIN 2) (HUMAN MONOCLONAL RO7250284 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL RO7250284 .KAPPA.-CHAIN

ZIFIBANCIMIG [INN]